🚨 For the first time, surgeons have removed a brain tumor while receiving live guidance from an artificial intelligence system analyzing the operation as it happened. The procedure was performed at London’s National Hospital for Neurology and Neurosurgery on a 48-year-old patient with an 11 mm tumor on his pituitary gland. The tumor was dangerously close to structures responsible for vision, making the operation particularly delicate. During surgery, AI analyzed the live camera feed and identified important anatomy such as nerves and blood vessels, highlighting structures surgeons needed to avoid. The system had been trained using hundreds of previous surgical videos. The AI did not perform the surgery itself. The surgeons remained completely in control, with the technology essentially acting as an additional set of eyes and providing real-time decision support. The patient had been at risk of losing his sight. Reports say his vision improved following the operation, and the procedure demonstrated how AI could potentially make some of the most delicate surgeries safer and more precise. This is where medical AI could become especially powerful: not replacing surgeons, but helping them recognize critical anatomy and make better-informed decisions while an operation is actually happening.

"Mind blown. The responses it gave were pulled from sources we trust, but also based on what it was hearing in the visit in real time. The updated Abridge clinical decision support just blew me away." —Hematology/Oncology & Palliative Care Clinician at a large, urban health system Abridge Clinical Decision Support surfaces relevant, evidence-based information at the point of care. When clinicians ask questions, CDS insights are grounded in the clinical conversation, EHR context, and informed by a growing list of trusted sources: - UpToDate (owned by Wolters Kluwer) - The New England Journal of Medicine - JAMA (published by AMA) - American Heart Association - American Diabetes Association - American Family Physician (published by AAFP) - Journal of Clinical Oncology (published by ASCO) - Neurology (published by AAN) - EBMCalc No more surfing tabs. No more switching context. No more turning away from the patient. Just the information you need, exactly when you need it, grounded in clinical context. Learn more at

Researchers have studied "SuperAgers," older adults whose memories remain exceptionally sharp. Now, scientists are looking at another group: "super movers," people in their 80s who walk significantly faster than their peers. Faster-than-normal walkers were substantially less likely to develop cognitive impairment, according to a new study published in the journal Neurology.

⚡️Neurotech Brief⚡️ Science Corp successfully implanted its biohybrid cortical sensor in a human patient for the first time. The device represents a novel integration of synthetic electronics with living biological tissue, utilizing thin-film electrode arrays seeded with living neurons. The biohybrid interface was confirmed to record neural signals through the living neuronal layer, demonstrating functional integration between electronic components and biological neural tissue. This capability indicates a significant advancement in brain-computer interface technology. The implantation of a biohybrid sensor marks a critical step in neurotechnology development. The merger of synthetic materials with living neural cells creates new possibilities for developing neural interfaces with improved biocompatibility and signal fidelity. This achievement represents progress toward therapeutic applications in neurology and neuroprosthetics. Source: Web and IT News

⚡️Neurotech Brief⚡️ Paradromics launched the Connect-One early feasibility study for Connexus, a fully implantable brain-computer interface designed to restore speech in patients with severe paralysis. FDA IDE approval was granted for the trial. Trial locations: The clinical study is being conducted at three sites: Sacramento CA, Boston MA, and Ann Arbor MI. These sites represent leading institutions in neurology and neurotech research. Clinical significance: The Connexus system represents progress toward functional restoration for severely paralyzed patients, with fully implantable design potentially improving quality of life and long-term usability compared to external systems. @Paradromics Source: Paradromics

In 2014, Robin Williams was 63 and living in Marin County, California, when a strange medical mystery began tightening around him. Parkinson’s had a name, but his fear, confusion, sleepless nights, and mental fog still did not. At home, Susan Schneider Williams was watching the man the world knew for laughter slowly become trapped inside symptoms nobody could fully explain. The comic genius was still there, but something hidden kept changing the rules. The clues did not arrive like one clear warning. They came scattered. Stomach pain. Insomnia. A poor sense of smell. Anxiety that felt too sharp. Then came moments that scared Susan because they did not match the Robin she knew. He could be present one minute, then caught in fear the next. Susan later wrote, “By wintertime, problems with paranoia, delusions and looping, insomnia, memory, and high cortisol levels, just to name a few, were settling in hard.” That sentence became one of the most painful pieces of the puzzle. Robin Williams had spent decades turning speed, memory, emotion, and chaos into art. His mind was part of his magic. On stage, he could jump between voices like flipping channels inside his own brain. In “Mrs. Doubtfire” (1993), he made families laugh through pain. In “Good Will Hunting” (1997), he made silence feel heavy. But inside his own body, something was now stealing the very tools that made him Robin. The fear was not normal stress. Susan had lived beside him. She knew the difference between worry and something deeper. Later, she said, “But Robin would remain in a heightened state of fear and anxiety that led to irrational paranoia. It was painful to watch.” That was the nightmare. He was not simply sad. He was frightened by changes he could feel but could not name. By May 2014, doctors gave him a Parkinson’s disease diagnosis. It explained some things. His left hand had a tremor. His body had slowed. His face sometimes looked less expressive. His movement was changing. A diagnosis should have brought comfort, but for Robin it felt incomplete. He asked whether he had Alzheimer’s. He asked about dementia. He asked about schizophrenia. The answer was no, but the questions themselves were clues. That is where the mystery becomes darker. The diagnosis was not fake, but it was not the full picture. Parkinson’s explained the movement symptoms. It did not fully explain the paranoia, confusion, insomnia, panic, and strange mental changes. Robin was being treated for what doctors could see clearly. The real enemy was still hiding behind overlapping symptoms. Susan watched him struggle with things that once came naturally. Lines became harder. Confidence cracked. Sleep disappeared. Some days carried flashes of the old Robin, then the fog would return. He knew something was wrong, and that knowledge hurt him. It was like a brilliant machine was short-circuiting from the inside while everyone outside kept searching for the right switch. On August 11, 2014, Robin Williams died by suicide at his home in Tiburon, California. He was 63. The public story quickly became simple. People said depression. People remembered his past battles. But Susan kept trying to explain that the truth was not that simple. Later, the autopsy revealed diffuse Lewy body disease. The hidden disease had spread through his brain and brain stem. That discovery changed the whole file. Lewy body dementia can affect thinking, movement, sleep, mood, behavior, and perception. It can look like Parkinson’s. It can look like psychiatric illness. It can make a person seem anxious, paranoid, forgetful, or unlike himself. In Robin’s case, it had been quietly attacking the center of who he was. Susan later said, “Depression is a symptom of LBD and it’s not about psychology, it’s rooted in neurology. His brain was falling apart.” Those words did not erase the grief, but they gave the mystery its missing name. Robin had not simply lost a private emotional battle. He had been fighting a brain disease that was almost impossible to fully identify while he was alive. Later, Susan described him with heartbreaking clarity. “Robin is and will always be a larger-than-life spirit who was inside the body of a normal man with a human brain.” That human brain was under attack before anyone could see the whole map. The mystery was what no one could name in time.

Serious side effects—including neurological and autoimmune disorders—have been reported after hepatitis B vaccination. But according to the Institute of Medicine, the evidence is “inadequate to accept or reject” a causal link. Parents, you have every right to ask questions and explore the science for yourself. 👉 Start here: #vaccines#